[1]
C. Dessers, “Impact of RSV Immunization with Nirsevimab (Beyfortus®) on RSV-Related Hospitalizations of Pediatric Patients in a Regional Hospital in Belgium”, Belg J Paediatr, vol. 27, no. 1, pp. 61–62, Apr. 2025.